NCT00723697View on ClinicalTrials.gov

Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)

CompletedOBSERVATIONAL
Enrollment

1,307

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
BuprenorphineNaloxoneOpiate-related DisordersOpiate DependenceDrug Abuse
Interventions
DRUG

buprenorphine

0.4, 2, or 8 mg sublingual tablets

Sponsors

Lead Sponsor

Indivior Inc.
All Listed Sponsors
lead

Indivior Inc.

INDUSTRY

NCT00723697 - Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) | Biotech Hunter | Biotech Hunter